{"id":"https://openalex.org/W4384469458","doi":"https://doi.org/10.25251/skin.7.supp.224","title":"Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study","display_name":"Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study","publication_year":2023,"publication_date":"2023-07-17","ids":{"openalex":"https://openalex.org/W4384469458","doi":"https://doi.org/10.25251/skin.7.supp.224"},"language":"en","primary_location":{"id":"doi:10.25251/skin.7.supp.224","doi":"https://doi.org/10.25251/skin.7.supp.224","is_oa":true,"landing_page_url":"https://doi.org/10.25251/skin.7.supp.224","pdf_url":"https://jofskin.org/index.php/skin/article/download/2186/1790","source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jofskin.org/index.php/skin/article/download/2186/1790","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084041900","display_name":"M.M. Senna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289019353","display_name":"Lahey Hospital and Medical Center","ror":"https://ror.org/03mbq3y29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289019353"]},{"id":"https://openalex.org/I4210106397","display_name":"Lahey Medical Center","ror":"https://ror.org/01m178w43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryanna Senna","raw_affiliation_strings":["Lahey Hospital and Medical Center, Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lahey Hospital and Medical Center, Burlington, MA","institution_ids":["https://openalex.org/I1289019353","https://openalex.org/I4210106397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078964682","display_name":"Seth B. Forman","orcid":"https://orcid.org/0000-0001-5800-1856","observed_orcids":["https://orcid.org/0000-0001-5800-1856"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Forman","raw_affiliation_strings":["ForCare Medical Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ForCare Medical Center, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002096850","display_name":"Lindsey A. Bordone","orcid":"https://orcid.org/0000-0001-8700-890X","observed_orcids":["https://orcid.org/0000-0001-8700-890X"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey Bordone","raw_affiliation_strings":["Columbia University Medical Center, NY, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, NY, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072784314","display_name":"P. de la Cueva Dobao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165557","display_name":"Hospital Universitario Infanta Leonor","ror":"https://ror.org/05nfzf209","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210165557"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo De La Cueva Dobao","raw_affiliation_strings":["Departamento de Dermatolog\u00eda, Hospital Universitario Infanta Leonor, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Dermatolog\u00eda, Hospital Universitario Infanta Leonor, Madrid, Spain","institution_ids":["https://openalex.org/I4210165557"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089890051","display_name":"Robert A. Wolk","orcid":"https://orcid.org/0000-0001-8581-6647","observed_orcids":["https://orcid.org/0000-0001-8581-6647"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Wolk","raw_affiliation_strings":["Pfizer Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029796262","display_name":"Samuel H. Zwillich","orcid":"https://orcid.org/0009-0003-9103-4176","observed_orcids":["https://orcid.org/0009-0003-9103-4176"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Zwillich","raw_affiliation_strings":["Pfizer Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fan Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fan Zhang","raw_affiliation_strings":["Pfizer Inc, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Groton, CT","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043302763","display_name":"Haytham Mohamed Ahmed","orcid":"https://orcid.org/0000-0002-2883-3317","observed_orcids":["https://orcid.org/0000-0002-2883-3317"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haytham Mohamed Ahmed","raw_affiliation_strings":["Pfizer Inc, Dubai, United Arab Emirates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Dubai, United Arab Emirates","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086564157","display_name":"Liza Takiya","orcid":"https://orcid.org/0000-0002-6296-7685","observed_orcids":["https://orcid.org/0000-0002-6296-7685"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Takiya","raw_affiliation_strings":["Pfizer Inc, Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Collegeville, PA, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"4","first_page":"s224","last_page":"s224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alopecia-areata","display_name":"alopecia areata","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ritlecitinib","display_name":"ritlecitinib","score":1.0},{"id":"https://openalex.org/keywords/hair-regrowth","display_name":"hair regrowth","score":0.8360000252723694},{"id":"https://openalex.org/keywords/scalp-hair-loss","display_name":"scalp hair loss","score":0.8539999723434448},{"id":"https://openalex.org/keywords/eyebrow-hair","display_name":"eyebrow hair","score":0.8960000276565552},{"id":"https://openalex.org/keywords/nonresponders","display_name":"non-responders","score":0.593999981880188},{"id":"https://openalex.org/keywords/salt-score","display_name":"SALT score","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-response-over-time","display_name":"treatment response over time","score":0.43299999833106995},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7419999837875366},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.40299999713897705},{"id":"https://openalex.org/keywords/loading-dose","display_name":"loading dose","score":0.5879999995231628},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5759999752044678},{"id":"https://openalex.org/keywords/upper-respiratory-tract-infection","display_name":"upper respiratory tract infection","score":0.7910000085830688},{"id":"https://openalex.org/keywords/nasopharyngitis","display_name":"nasopharyngitis","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C2777524370","wikidata":"https://www.wikidata.org/wiki/Q5075435","display_name":"Alopecia areata","level":2,"score":0.8758038282394409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8303157687187195},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.7998219728469849},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7188987731933594},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6857762336730957},{"id":"https://openalex.org/C2779884382","wikidata":"https://www.wikidata.org/wiki/Q160108","display_name":"Eyelash","level":2,"score":0.666722297668457},{"id":"https://openalex.org/C2779022956","wikidata":"https://www.wikidata.org/wiki/Q43748","display_name":"Eyebrow","level":2,"score":0.5535444021224976},{"id":"https://openalex.org/C2776360568","wikidata":"https://www.wikidata.org/wiki/Q2697787","display_name":"Hair loss","level":2,"score":0.5022356510162354},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.46542733907699585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39741942286491394},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32277819514274597},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.311448335647583},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/skin.7.supp.224","doi":"https://doi.org/10.25251/skin.7.supp.224","is_oa":true,"landing_page_url":"https://doi.org/10.25251/skin.7.supp.224","pdf_url":"https://jofskin.org/index.php/skin/article/download/2186/1790","source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/skin.7.supp.224","doi":"https://doi.org/10.25251/skin.7.supp.224","is_oa":true,"landing_page_url":"https://doi.org/10.25251/skin.7.supp.224","pdf_url":"https://jofskin.org/index.php/skin/article/download/2186/1790","source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320332071","display_name":"LEO Pharma","ror":"https://ror.org/05tzrdd39"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4384469458.pdf","grobid_xml":"https://content.openalex.org/works/W4384469458.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387015675","https://openalex.org/W4387014384","https://openalex.org/W4388626089","https://openalex.org/W4403500339","https://openalex.org/W4404455253","https://openalex.org/W4403597455","https://openalex.org/W4324057567","https://openalex.org/W4416141283","https://openalex.org/W7127912173","https://openalex.org/W4407718800"],"abstract_inverted_index":{"Background:":[0],"This":[1,101],"post":[2],"hoc":[3],"analysis":[4,102],"of":[5,126],"the":[6,88,170,173,230],"ALLEGRO":[7],"phase":[8],"2b/3":[9],"study":[10],"(NCT03732807)":[11],"assessed":[12],"response":[13,37,182,188,232,267,273],"to":[14,92,195],"ritlecitinib,":[15],"an":[16],"oral":[17],"JAK3/TEC":[18],"family":[19],"kinase":[20],"inhibitor,":[21],"between":[22],"Weeks":[23,221],"28-48":[24],"among":[25,152],"patients":[26,104,153,171,227],"with":[27,47,154,192,257,260,278],"alopecia":[28],"areata":[29],"(AA)":[30],"who":[31,116,176,262],"did":[32,177],"not":[33,118,178,228],"meet":[34,179,264],"target":[35,265],"efficacy":[36,266],"criteria":[38],"at":[39,120,160,183,189,197,220,233,268,274],"Week":[40,79,99,121,166,184,190,198,234,241,269],"24.":[41,235],"Methods:":[42],"Patients":[43,256],"aged":[44],"\u226512":[45],"years":[46],"AA":[48,258],"and":[49,87,162,209,213,215,218,223,253],"\u226550%":[50],"scalp":[51,133],"hair":[52],"loss":[53],"received":[54],"daily":[55,70,113],"ritlecitinib":[56,81,93,106,174,261,280],"10":[57],"mg":[58,67,97,110],"(included":[59],"for":[60,75,205,226],"dose":[61],"ranging":[62],"only),":[63],"30":[64,107],"or":[65,73,95,108,139,142,147,157],"50":[66,96,109],"(\u00b14-week":[68,111],"200-mg":[69,112],"loading":[71,114],"dose),":[72],"placebo":[74,89],"24":[76,270],"weeks.":[77],"After":[78],"24,":[80,122,185],"groups":[82,175],"continued":[83,279],"their":[84],"assigned":[85],"doses":[86],"group":[90],"switched":[91],"200/50":[94],"through":[98,165,240],"48.":[100,167,199,242],"included":[103],"receiving":[105],"dose)":[115],"had":[117,187],"responded":[119],"based":[123],"on":[124],"Severity":[125],"Alopecia":[127],"Tool":[128],"(SALT)":[129],"score":[130,137,159],"\u226420":[131,181],"(\u226420%":[132],"without":[134],"hair),":[135],"SALT":[136,180,206],"\u226410,":[138],"eyebrow":[140],"(EBA)":[141],"eyelash":[143],"(ELA)":[144],"assessment":[145],"(normal":[146],"\u22652-grade":[148],"improvement":[149],"from":[150],"baseline":[151],"abnormal":[155],"EBA":[156,211],"ELA":[158,216],"baseline),":[161],"followed":[163],"them":[164],"Results:":[168],"Of":[169],"in":[172],"5-8%":[186],"28,":[191],"rates":[193],"increasing":[194],"22-34%":[196],"A":[200],"similar":[201],"trend":[202],"was":[203,237],"observed":[204],"\u226410":[207],"(6-12%":[208],"20-25%),":[210],"(8-14%":[212],"20-33%),":[214],"(4-15%":[217],"17-30%)":[219],"28":[222],"48,":[224],"respectively,":[225],"achieving":[229],"respective":[231],"Ritlecitinib":[236],"well":[238],"tolerated":[239],"Most":[243],"common":[244],"adverse":[245],"events":[246],"were":[247],"upper":[248],"respiratory":[249],"tract":[250],"infection,":[251],"nasopharyngitis,":[252],"headache.":[254],"Conclusion:":[255],"treated":[259],"don\u2019t":[263],"may":[271],"achieve":[272],"later":[275],"time":[276],"points":[277],"treatment.":[281]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-07-17T00:00:00"}